Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q73980526)
Watch
English
Effectiveness of antihyperlipidemic drug management in clinical practice
scientific article published on 01 November 1999
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10890267
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10890267%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
title
Effectiveness of antihyperlipidemic drug management in clinical practice
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10890267
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10890267%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
author name string
Andrade SE
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10890267
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10890267%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
Saperia GM
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10890267
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10890267%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
Berger ML
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10890267
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10890267%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
Platt R
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10890267
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10890267%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
publication date
1 November 1999
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10890267
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10890267%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
published in
Clinical Therapeutics
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10890267
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10890267%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
volume
21
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10890267
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10890267%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
issue
11
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10890267
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10890267%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
page(s)
1973-1987
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10890267
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10890267%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
cites work
Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2986743-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2986743-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2986743-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2986743-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2986743-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Discontinuations of antihyperlipidemic drug therapy: assessment by means of automated databases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2986743-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Persistence of use of lipid-lowering medications: a cross-national study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2986743-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Apparent discontinuation rates in patients prescribed lipid-lowering drugs.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2986743-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Drug therapy for hypercholesterolemia in patients with cardiovascular disease: factors limiting achievement of lipid goals
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2986743-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2986743-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Endothelial dysfunction: does it matter? Is it reversible?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2986743-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2986743-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2986743-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2986743-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
HMG-CoA Reductase Inhibitors Decrease CD11b Expression and CD11b-Dependent Adhesion of Monocytes to Endothelium and Reduce Increased Adhesiveness of Monocytes Isolated From Patients With Hypercholesterolemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2986743-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cost-effectiveness of pravastatin in secondary prevention of coronary artery disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2986743-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2986743-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cutting into cholesterol. Cost-effective alternatives for treating hypercholesterolemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2986743-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cost-effectiveness of interventions to prevent or treat coronary heart disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2986743-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0149-2918(00)86743-0
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10890267
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10890267%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
PubMed publication ID
10890267
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10890267
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10890267%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit